Syntekabio Selected as Supplier for Data Voucher Support Project
[Asia Economy Reporter Chunhee Lee] AI drug development company Syntekabio announced on the 12th that it has been selected as a supplier company for the ‘2023 Data Voucher Support Project’ organized by the Ministry of Science and ICT and the Korea Data Industry Promotion Agency.
The Data Voucher Support Project is a program that supports demand companies in the form of vouchers to receive data purchase and processing services from supplier companies, aimed at data-driven business innovation and the development of new products or services.
Through this project, Syntekabio plans to provide demand companies with AI synthetic drug and protein interaction data analysis services using ‘DeepMatcher-HIT’ and AI neoantigen data analysis services using ‘NEO-ARS’.
Demand companies participating in the Data Voucher Support Project are selected through screening. Based on last year’s standards, demand companies received vouchers worth up to 45 million KRW for general data processing and up to 70 million KRW for AI data processing per business project per company. This year’s demand companies will be recruited through a future announcement.
Syntekabio plans to accept applications from demand companies wishing to use DeepMatcher or NEO-ARS services and provide customized consulting related to AI drug development.
Hot Picks Today
"I Should Have Told My Mom Not to Throw Them Away"... Soared 3,821% in 20 Years, 8 Times More Than the S&P 500
- Despite the Sharp Drop in Samsung Electronics, "600,000 Won Is Within Reach"... The Basis for the 'Record-Breaking Jackpot' Scenario
- Western Gyeongnam Four County Governors Gather to Seek Solutions for Joint Issues
- "Another Warning for Jeju: 'Chinese Language Everywhere—Island on the Brink of Suffocation'"
- "Trust Us, Just This Once" From Reviled Pest to Savior: Cyborg Insects Emerge
A Syntekabio official stated, “This Data Voucher Project will lower the entry barriers for small and medium biotech companies and startups in AI drug development,” adding, “We will provide the services that demand companies want.”
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.